Skip to main content

Table 3 Distribution of propensity score by treatment group in the ALLEGRO study

From: Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

 

Treatment group

Placebo

Laquinimod 0.6 mg/day

Estimate

Estimate

Quartile

  

Maximum

Upper quartile

0.647

0.547

Median

0.540

0.448

Lower quartile

0.445

0.339

Minimum

0.106

0.034

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us